Shanghai Xuerong Bio-Technology Co Ltd (300511) — Working Capital to Net Assets Ratio
Shanghai Xuerong Bio-Technology Co Ltd (300511) has a Working Capital to Net Assets ratio of -89.3% as of June 2025. Working capital of CN¥-1.05 Billion (current assets of CN¥469.65 Million minus current liabilities of CN¥1.52 Billion) is measured against net assets of CN¥1.17 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Shanghai Xuerong Bio-Technology Co Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Shanghai Xuerong Bio-Technology Co Ltd Working Capital to Net Assets (2015–2024)
This chart shows how Shanghai Xuerong Bio-Technology Co Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the ratio stands at -89.3%, reflecting working capital of CN¥-1.05 Billion against net assets of CN¥1.17 Billion CNY. Check 300511 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Shanghai Xuerong Bio-Technology Co Ltd (2015–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai Xuerong Bio-Technology Co Ltd from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Shanghai Xuerong Bio-Technology Co Ltd.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -170.3% | CN¥-1.40 Billion | CN¥823.32 Million | CN¥546.31 Million | CN¥1.95 Billion | ▼ -76.3 pp |
| 2023 | -94.0% | CN¥-1.35 Billion | CN¥1.43 Billion | CN¥766.60 Million | CN¥2.11 Billion | ▼ -87.5 pp |
| 2022 | -6.5% | CN¥-104.97 Million | CN¥1.63 Billion | CN¥1.19 Billion | CN¥1.30 Billion | ▲ +37.8 pp |
| 2021 | -44.2% | CN¥-731.70 Million | CN¥1.65 Billion | CN¥874.94 Million | CN¥1.61 Billion | ▼ -36.5 pp |
| 2020 | -7.7% | CN¥-156.74 Million | CN¥2.02 Billion | CN¥1.23 Billion | CN¥1.39 Billion | ▲ +25.9 pp |
| 2019 | -33.7% | CN¥-585.61 Million | CN¥1.74 Billion | CN¥701.13 Million | CN¥1.29 Billion | ▲ +3.8 pp |
| 2018 | -37.4% | CN¥-587.31 Million | CN¥1.57 Billion | CN¥805.89 Million | CN¥1.39 Billion | ▲ +32.6 pp |
| 2017 | -70.0% | CN¥-991.13 Million | CN¥1.42 Billion | CN¥588.60 Million | CN¥1.58 Billion | ▼ -29.0 pp |
| 2016 | -40.9% | CN¥-528.02 Million | CN¥1.29 Billion | CN¥406.37 Million | CN¥934.39 Million | ▲ +50.0 pp |
| 2015 | -91.0% | CN¥-584.83 Million | CN¥642.99 Million | CN¥307.90 Million | CN¥892.73 Million | — |